ABSTRACT. To determine potential mechanisms by and frequency of hypothalamic GnRH release in late puwhich androgens alter gonadotropin secretion and elimibertal boys. (Pediatr Res 35: 102-106,1994) nation in the pubertal male, we administered the potent nonsteroidal androgen receptor blocking agent, flutamide, to eight males with Tanner IV or V genital development.
Venous blood samples were obtained every 10 min for 24 GnRH, gonadotropin-releasing hormone h and assayed for LH by a sensitive and high-precision L,, body distribution volume in liters fluorimmunoassay. Subjects were studied before and after the administration of flutamide. Deconvolution analysis was used to assess specific pulsatile LH secretory characteristics and estimate LH production and metabolic clearance rates quantitatively. After antagonism of endogenous androgen action, mean 24-h serum LH concentrations increased significantly. An increased mean 24-h LH production rate, without evident changes in serum LH half-life, accounted for the increase in average serum LH levels. The increased daily secretion rate of LH was in turn due to both an augmented mass of LH released per secretory episode and increased frequency of secretory events. There was no demonstrable change in the maximal rate of LH secretion attained within each secretory event. Serum concentrations of total testosterone, free-testosterone, and 17@-estradiol all increased during blockade of androgen action. Administration of the antiandrogen had no measurable effect on the pituitary response to a single maximally effective dose of exogenous gonadotropin releasing hormone (GnRH). These results indicate that, in the late pubertal male, endogenous androgen exerts negative feedback control of gonadotropin secretion primarily at a hypothalamic site reflected by regulation of the frequency of pulsatile LH secretion. Antiandrogen had no discernible effects on exogenous GnRH-stimulated pituitary LH release or on the elimination rate of LH, but amplified the mass of LH secreted in response to endogenous GnRH. Assuming that pituitary response to exogenous GnRH reflects responsivity to endogenous releasing factor, we can infer an augmentation of the endogenous GnRH stimulus when androgen negative feedback is withdrawn. Accordingly, we suggest that endogenous androgen acting via androgen receptors negatively regulates both the amount The dynamic process of normal human puberty is heralded by dramatic increases in nocturnal gonadotropin secretion (1) (2) (3) . This awakening of the CNS-hypothalamic-pituitary axis then augments gonadal steroidogenic activity, manifested as increasing serum levels of sex steroid hormones. As the adolescent matures, a feedback control system develops whereby gonadal steroid hormones modulate pulsatile gonadotropin secretion. Although it appears that androgens inhibit gonadotropin release by acting at both the hypothalamus and pituitary gland (4, 5 ) , evidence exists supporting a developmental process of such feedback control.
In the pubertal male, androgens may act predominantly at the hypothalamus (6) (7) (8) . As full sexual maturation is achieved, studies in GnRH-deficient patients suggest that the pituitary becomes an additional site of androgen negative feedback ( 5 , 9 ) . However, other investigators (10, 11) have not found a pituitary effect of androgen feedback action in the intact adult male. In addition to a direct effect of androgens via their respective receptormediated pathways, the aromatized product, estrogen, also exerts modulatory control of gonadotropin secretion (1 2-16). Thus, the sex steroid hormones may regulate the reproductive axis at multiple sites via alternate mechanisms.
To investigate potential mechanism(s) whereby testosterone, and/or its metabolites, alter circulating gonadotropin levels in the late pubertal male, we used the techniques of frequent venous sampling, sensitive LH fluoroimmunoassay, deconvolution analysis, antiandrogen administration, and GnRH stimulation testing. Antiandrogen administration was used to introduce selective partial blockade of androgen negative feedback via the androgen receptor. The method of deconvolution analysis a p plied here assesses specific secretory characteristics and the simultaneously occurring process of hormone elimination (17, 18) . The application of this computer-based mathematical model to hormone concentration-versus-time series also allows estimates of subject-specific hormone production rates. Using these combined strategies, we have explored the principal loci of androgen negative feedback in the late pubertal male.
MATERIALS AND METHODS
were appraised using cosinor analysis as described previously Subjects. Eight normal, healthy late pubertal (Tanner genital stage IV or V) males participated in this study; pubertal staging was performed according to the method of Marshall and Tanner (19) . Ages ranged from 13.8 to 17.2 y. The height and weight of each subject were between the 5th and 95th percentiles for chronologic age (based on standards from the National Center for Health Statistics). Skeletal ages were within 2 SD for chronologic age; values of body mass index [weight/height2 (20) ] were -0.12 f 0.40 SD for skeletal age. All subjects were free of medical illness, alcohol or drug abuse, recent weight changes, and endocrine dysfunction.
Protocol. The study protocol was approved by the Human Investigation Committee at the University of Virginia and was performed in the University of Virginia General Clinical Research Center. Participants were informed of the details of the investigation. Legal consent and assent were then provided by the parents and the adolescents, respectively.
All subjects were admitted on two occasions in randomized order. For the baseline (BASELINE) admission, no medications were taken before the study. For the treatment (FLUTAMIDE) admission, subjects were administered flutamide (Eulexin, Schering Corp., Kenilworth, NJ) 250 mg orally 4 times a day for the 3 days before-and throughout-the admission. For each admission, a heparin lock was placed in a forearm vein approximately 1 h before venous sampling. Blood samples were obtained at 10-min intervals for 24 h beginning at 0800 h. At the end of this time, GnRH (100 pg) was administered intravenously; blood samples were then obtained every 10 min for an additional 60 min. All other serum hormone concentrations were measured in a blood sample obtained at 0800 h. Subjects were allowed normal ambulatory activity and received meals at 0900, 1200, and 1730 h; a caffeine-free snack was provided at 2100 h. Subjects were required to be in bed with the room lights turned out from 2300 to 0600 h. No adverse effects of flutamide were reported.
Assays. Serum LH concentrations were determined in duplicate by fluorimmunoassay (Delfia hLH Spec, Pharmacia EN1 Diagnostics Inc., Columbia, MD). The limit of assay detection is 0.3 IU/L (First International Reference Preparation) with mean intra-and interassay coefficients of variation of 5.1 and 4.3%, respectively. All samples obtained from a given subject were measured in a single assay run to avoid interassay variability. Serum FSH concentrations were determined by immunoradiometric assay (Nichols Laboratories, San Juan Capistrano, CA). Total and free serum testosterone and total serum estradiol were determined in single-run assays using commercial solid phase RIA (Coat-A-Count, Diagnostic Products Corporation, Los Angeles, CA). Serum concentrations of 2-hydroxyflutamide, the biologically active metabolite of flutamide, were measured by HPLC through the generous cooperation of Schering Corporation.
Deconvolution analysis. Deconvolution analysis is a mathematical technique that, when applied to hormone concentrationversus-time series, estimates subject-specific measures of hormone production and clearance (1 7, 18) . Among these are: I ) the number and positions in time of significant secretory episodes, 2) secretory burst halfduration (duration of the calculated secretory episode at half-maximal amplitude), 3) amplitude (maximal secretory rate in each secretory burst), and 4) hormone half-life corresponding to a disappearance rate constant. The elimination process here was described by a monoexponential model. The mass of hormone released per secretory episode is determined as the analytical area of the secretory rate-versustime curve in a given burst. No tonic (nonpulsatile) secretion was necessary to model the present experimental data. Total daily production rates were derived as the product of secretory burst frequency and the mass of hormone released per secretory event.
Potential day-night differences of serum LH concentrations
Statistical analysis. Comparisons between the baseline and the flutamide-treated state were made using the paired two-tailed t test. Secretory parameters were log-transformed before statistical analysis to meet criteria of normal distribution (22) . Statistical significance was accepted at a p value of <0.05. Results are reported as the mean f SEM.
RESULTS
Ef/i.cts of antagonism of androgen action on serum concentrations of FSH and sex steroid hormones. As summarized in Table  1 Effects of androgen receptor blockade on 24-h mean serum LH concentrations and on L H production and elimination rates. Representative graphs obtained by deconvolution analysis of the LH concentration-versus-time data series are illustrated in Figure  1 ; representative predicted (reconvolution curve) fits to the concentration-versus-time series and LH secretory rate-versus-time curves are depicted for each of two study subjects.
The effects of androgen-receptor blockade on specific pulsatile LH secretory and elimination parameters are summarized in No significant day-night differences of serum LH concentrations were observed for either experimental condition.
Efects of antiandrogen administration on GnRH-stimulated LH secretion. As summarized in Table 2 , flutamide administration had no demonstrable effect on the pituitary response to a maximal dose of exogenous GnRH. No changes in peak serum 25 . Note the differences in vertical axis scale between the two subjects. Results for all eight subjects are summarized in Table 2 .
LH concentrations ( 19 * 3 versus 17 f 2 IU/L) or the incremental increase in serum LH levels ( 16 * 2 versus 12 + 2 IU/L) were observed after GnRH stimulation in the androgen receptorblocked adolescent male.
DISCUSSION
Sex steroid hormones play a major role in the feedback regulation of the CNS-hypothalamic-pituitary-gonadal axis. Depending upon the species, age, and experimental conditions, androgens appear to inhibit gonadotropin secretion by acting at both the hv~othalamus and pituitary gland (4) . Available evidence suggests that a developmental pio&ss occurs during human male puberty such that, after hypothalamic maturation is achieved, the pituitary gland becomes an additional site of androgen negative-feedback action (5,9). All of the foregoing inferences were derived from GnRH-deficient subjects treated with pulsatile GnRH or after the administration of pharmacological amounts of androgen. In intact men, LH immunoassay and bioassay both support increased endogenous GnRH release with or without an increased frequency of hypothalamic activity (10, 11). To our knowledge, no comparable data are available to assess androgennegative feedback in the later stages of puberty in the male. Therefore, we sought to determine potential mechanisms subserving gonadal steroid hormone modulation of gonadotropin secretion in the pubertal male. To accomplish this goal, the techniques of intensive venous sampling, sensitive, specific and precise LH fluorimmunoassay, deconvolution analysis, and * Peak LH represents the maximal serum LH concentration achieved after GnRH stimulation and ALH represents the arithmetic difference between the peak LH concentration and the mean serum level of LH before GnRH administration. Data are mean + SEM (n = 8 subjects).
GnRH-stimulation testing were utilized in a cohort of late pubertal male subjects administered the potent, nonsteroidal antiandrogen, flutamide (24) .
The pattern of circulating gonadotropin concentrations in the adolescent male is pulsatile (2, 3, 25) . Presumably, these momentary surges in serum gonadotropin levels result from episodic stimulation of the pituitary by hypothalamic GnRH. Studies in animals (26) (27) (28) have suggested a coordinate relationship between the hypothalamic neuronal "pulse-generator," hypophyseal portal GnRH concentrations and pulsations in plasma LH levels. Consequently, indirect inferences about GnRH action may be based on patterns of peripheral LH concentrations in the human.
We observed discrete episodes of gonadotropin secretion in the late pubertal male. LH release occurred in random bursts of finite duration without demonstrable tonic hormone secretion. The frequency of such LH secretory events in our subjects corresponded to approximately one event every 100 min, which is in good agreement with the frequency of serum LH pulsations observed by other investigators (2, 3, 25) . Hence, the fluctuating levels of circulating gonadotropins can be ascribed to burst-like secretion of pituitary LH, which is then acted upon simultaneously by metabolic clearance. By inference, dynamic variations in GnRH release and action underlie the pulsatile pattern of LH release in the pubertal male.
When androgen feedback action is attenuated by therapeutically effective serum concentrations of 2-hydroxyflutamide as measured here, heightened LH production occurs in the pubertalaged male. The mechanism of increased daily LH production was clarified further by deconvolution analysis, which showed that contributing to greater LH secretion are increases in LH secretory burst frequency and the mass of hormone released per secretory episode. No demonstrable change in the calculated elimination rate of LH occurs during androgen-receptor antagonism. The derived estimate of serum LH half-life in our subjects agrees closely with the range of 74 to 1 1 1 min observed for the slow component disappearance of exogenously administered purified human pituitary LH (immunoassayable and bioassayable gonadotropin) in the adult male (29) . The net result of antiandrogen administration is higher 24-h mean serum LH concentrations. These increased levels of serum LH assessed in an fluoroimmunoassay were presumably bioactive, because serum concentrations of total testosterone and estradiol and free testosterone all increased significantly. This pattern is consistent with that observed in inborn errors of the androgen receptor (e.g. testicular feminization), in which increased LH secretion occurs despite high circulating androgen and estrogen concentrations (12, 30) . Of interest, FSH concentrations did not increase significantly, which may reflect suppressive effects of the mild hyperestrogenemia on FSH secretion and/or increased negative feedback effects of nonsteroidal products of the testes, such as inhibin (not measured here). Thus, assuming that flutamide does not cause any changes in gonadotropin or steroid hormone distribution volumes or half-lives of elimination, our findings indicate that late pubertal males can amplify the daily production of bioactive LH via specific enhancement of LH secretory burst frequency and mass of hormone released per secretory event, when the negative feedback actions of endogenous androgens on the androgen receptor are relieved.
Flutamide administration had no demonstrable effect on GnRH-stimulated LH release suggesting that androgen does not influence gonadotropin secretion at the pituitary level. This finding supports the conclusion of Kletter and colleagues (8, 3 1) that, in the pubertal male, the principal site of androgen negativefeedback on the reproductive axis is the hypothalamus. Because LH secretory burst mass increased during flutamide treatment, we can suggest that the amount of endogenous GnRH released per burst also increased. We cannot discount the possibility, however, that provocation with submaximal doses of GnRH would reveal more subtle androgen-induced changes in gonadotrope secretory responses to the secretagogue. Because increased concentrations of testosterone and estrogen occurred as a result of heightened LH release during antiandrogen administration, we recognize the possibility that unopposed estrogen action might have diminished somewhat the pituitary response to GnRH stimulation (13, 32) . However, antiestrogen administration in young men does not augment the stimulatory effects of a submaximal dose of exogenous GnRH (15) on bioactive LH secretion. Accordingly, our demonstration of increased LH secretory burst frequency and mass with no changes in pituitary responsiveness to exogenous GnRH is consistent with heightened GnRH burst frequency and GnRH burst amplitude.
In summary, androgen negative-feedback action on the CNShypothalamic-pituitary axis is exerted primarily at the hypothalamus in the late pubertal-aged male. By attenuating androgen action in late pubertal boys, we can infer that physiological amounts of androgen dampen the activity of the GnRH pulsegenerator and the associated GnRH pulse stimulus to the pituitary, thereby providing effective modulatory control of pulsatile gonadotropin secretion in the young adult.
